The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis

Key Points

• Cognitive impairment may correlate with cholesterol-lowering drugs, impacting brain health directly.
• The review assesses data from multiple studies, providing a comprehensive overview of neurocognitive effects.
• Analysis of existing literature reveals a range of cognitive outcomes linked to drug intervention.
• These findings emphasize the need for deeper analysis, especially considering potential adverse effects.

Abstract